Indications
Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Benzamide, N-[(3R)-3-(2-Chloro-5-Fluorophenyl)-6-(5-Cyano[1,2,4]Triazolo[1,5-A]Pyridin-6-Yl)-2,3-Dihydro-1-Oxo-1H-Isoindol-4-Yl]-3-Fluoro-5-(Trifluoromethyl)-
Her2-Receptor Negative Breast Cancer
Relay Therapeutics, Inc.
P3
BB
(66)
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
Infantile Spasms
Children's Hospital of Orange County
P3
BB
(66)
Bezuclastinib
Gastrointestinal Stromal Tumor
Cogent Biosciences, Inc.
P3
BB
(66)
Binimetinib
Colon Carcinoma
AIO-Studien-gGmbH
P3
BB
(66)
Brilaroxazine
Schizophrenia
Reviva Pharmaceuticals
P3
BB
(66)
Busulfanum
Childhood Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
P3
BB
(66)
Busulfanum
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P3
BB
(66)
Busulfanum
Myelodysplastic Syndrome With Single Lineage Dysplasia
Fred Hutchinson Cancer Center
P3
BB
(66)
Cabazitaxel
Prostate Adenocarcinoma
ECOG-ACRIN Cancer Research Group
P3
BB
(66)
Cabozantinib
Differentiated Thyroid Carcinoma
Exelixis
P3
BB
(66)
Cabozantinib
Metastatic Carcinoma In The Bone
National Cancer Institute (NCI)
P3
BB
(66)
Cabozantinib
Neuroendocrine Neoplasm
Fox Chase Cancer Center
P3
BB
(66)
Capecitabine
Ovarian Carcinoma
OHSU Knight Cancer Institute
P3
BB
(66)
Capecitabine
Invasive Breast Carcinoma
Dr. Tabassum Wadasadawala
P3
BB
(66)
Capecitabine
Pancreatic Neuroendocrine Tumor
Gustave Roussy, Cancer Campus, Grand Paris
P3
BB
(66)
Capecitabine
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)
P3
BB
(66)
Capecitabine
Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(66)
Capecitabine
Rectal Neoplasm
Chongqing University Cancer Hospital
P3
BB
(66)
Capecitabine
Secondary Malignant Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(66)
Capecitabine
Breast Carcinoma
University Health Network, Toronto
P3
BB
(66)
Capivasertib
Her2-Receptor Negative Breast Cancer
West German Study Group
P3
BB
(66)
Capivasertib
Castration-Resistant Prostate Carcinoma
Karolinska Institutet
P3
BB
(66)
Carboplatin
Anus Basaloid Carcinoma
National Cancer Institute (NCI)
P3
BB
(66)
Carboplatin
Cloacogenic Carcinoma
National Cancer Institute (NCI)
P3
BB
(66)
Carboplatin
Breast Adenocarcinoma
Genmab
P3
BB
(66)
Showing 2401 to 2425 of 18,153 assets
Previous
Page 97 of 727
Next